YENOM NOTICIAS

Qué está moviendo el mercado.

Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.

CANC
Limpiar

Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.

finance.yahoo.comPOSITIVO

AI, Cancer Vaccines, and Next-Gen Medicine

(1:00) - What Is mRNA? Why Was The Breakthrough So Important? (4:30) - What Is The Difference Between Personalized And Traditional Cancer Treatments? (7:20) - How Close Is the Approval And Could It Work For Different Types of Cancer? (9:15…

finance.yahoo.comPOSITIVO

Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough

Merck MRK and Moderna MRNA delivered a significant breakthrough in melanoma treatment, with their jointly developed mRNA cancer vaccine showing positive results in its first-ever Phase 3 trial. This vaccine, combined with Merck's exemplary…

finance.yahoo.comPOSITIVO

Here's Why Biotech ETFs Are Rallying Hard

Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based exchange-traded fund (ETF) iShares Biotechno…

finance.yahoo.comNEGATIVO

Healthcare stocks are red-hot. Here are 3 picks from a fund manager up 41% this year.

Healthcare stocks have outperformed the technology sector since September. The Tema Oncology ETF is one fund that has had enjoyed a big rally, up 41% this year. David Song, the fund's manager, highlighted three stock picks for Business Ins…

finance.yahoo.comPOSITIVO

Be Thankful to These ETFs This Year

As Americans prepare for Thanksgiving, investors have their own reasons to be grateful this year – despite a year marked by dramatic twists in geopolitical scenario, technological sphere and Fed policy changes. Wall Street’s 2025 journey h…

finance.yahoo.comPOSITIVO

Inside the Recent Strength in Biotech ETFs

Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to date, IBB has risen 23.6% versus SPY’s…

seekingalpha.comPOSITIVO

SA Asks: Which oncology companies are attractive M&A targets?

[word m and a made with wood building blocks, stock image] Maksim Labkouski Which cancer drug developers are attractive takeover targets? We asked Seeking Alpha analysts BioCGT Investor [https://seekingalpha.com/author/biocgt-investor], AL…

finance.yahoo.comPOSITIVO

10 Best Performing Biotech ETFs in 2024

In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETF…

finance.yahoo.comPOSITIVO

11 Best Biotech ETFs To Buy

In this article, we discuss 11 best biotech ETFs to buy. If you want to skip our discussion on the biotech industry, head over to 5 Best Biotech ETFs To Buy. The new era in biotech is defined by the convergence of biology, data, and artifi…

finance.yahoo.comPOSITIVO

12 Best Healthcare ETFs To Buy

In this article, we discuss 12 best healthcare ETFs. If you want to skip our discussion on the healthcare market, head directly to 5 Best Healthcare ETFs To Buy. In December 2022, BlackRock highlighted concerns about the performance for th…